Weekly Investment Analysts’ Ratings Updates for Afya (AFYA)

A number of research firms have changed their ratings and price targets for Afya (NASDAQ: AFYA):

  • 11/16/2026 – Afya was downgraded by Wall Street Zen from “buy” to “hold”.
  • 11/8/2026 – Afya was upgraded by Wall Street Zen from “hold” to “buy”.
  • 11/5/2026 – Afya was upgraded by Morgan Stanley from “underweight” to “equal weight”. They now have a $12.60 price target on the stock.
  • 11/3/2026 – Afya was upgraded by Citigroup from “neutral” to “buy”. They now have a $12.00 price target on the stock, down from $16.00.
  • 11/3/2026 – Afya was downgraded by Zacks Research from “hold” to “strong sell”.
  • 11/3/2026 – Afya had its price target lowered by JPMorgan Chase & Co. from $19.00 to $17.50. They now have an “overweight” rating on the stock.
  • 10/31/2026 – Afya was downgraded by Wall Street Zen from “buy” to “hold”.
  • 10/29/2026 – Afya was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
  • 10/29/2026 – Afya was upgraded by Bank of America from “neutral” to “buy”. They now have a $16.00 price target on the stock.
  • 10/7/2026 – Afya was upgraded by JPMorgan Chase & Co. from “neutral” to “overweight”. They now have a $19.00 price target on the stock, down from $21.00.
  • 10/5/2026 – Afya was upgraded by Zacks Research from “strong sell” to “hold”.
  • 9/24/2026 – Afya was upgraded by Bradesco Corretora to “outperform”. They now have a $17.00 price target on the stock.

Afya Price Performance

Shares of Afya stock opened at $10.15 on Thursday. The business has a 50 day simple moving average of $12.58 and a two-hundred day simple moving average of $13.93. Afya Limited has a 12 month low of $9.66 and a 12 month high of $16.16. The stock has a market capitalization of $951.29 million, a P/E ratio of 5.97, a PEG ratio of 1.65 and a beta of 0.43. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.08 and a quick ratio of 2.08.

Insider Activity at Afya

In related news, insider Santos Welder Ferreira sold 4,161 shares of the business’s stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $13.30, for a total transaction of $55,341.30. Following the completion of the sale, the insider directly owned 35,000 shares in the company, valued at approximately $465,500. The trade was a 10.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.80% of the company’s stock.

Afya Limited is a Brazilian medical education and digital health company. Its education business offers undergraduate medical degree programs, medical residency preparation, postgraduate courses and continuing education for health professionals. The company also provides digital tools and services for medical students and practicing physicians, including clinical reference, practice-management and learning resources. These offerings support professionals at different stages of their medical careers.

Read More

Receive News & Ratings for Afya Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya Limited and related companies with MarketBeat.com's FREE daily email newsletter.